相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
MicroRNA-588 regulates invasion, migration and epithelial-mesenchymal transition via targeting EIF5A2 pathway in gastric cancer
Xiaorong Zhou et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Epithelial-mesenchymal transition (EMT): A biological process in the development, stem cell differentiation, and tumorigenesis
Tong Chen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2017)
HMGA2 regulates lung cancer proliferation and metastasis
Xiaotian Gao et al.
THORACIC CANCER (2017)
Intracellular protein degradation: From a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting
Aaron Ciechanover
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2017)
Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial-mesenchymal transition in bladder cancer
Zhan Shi et al.
TUMOR BIOLOGY (2016)
Metformin inhibits prostate cancer cell proliferation, migration, and tumor growth through upregulation of PEDF expression
Xiaowan Chen et al.
CANCER BIOLOGY & THERAPY (2016)
Silencing of HMGA2 promotes apoptosis and inhibits migration and invasion of prostate cancer cells
Zhan Shi et al.
JOURNAL OF BIOSCIENCES (2016)
Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway
Xiao-Peng Zhao et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
Fa-Xing Yu et al.
CELL (2015)
The Hippo Pathway Effector YAP Regulates Motility, Invasion, and Castration-Resistant Growth of Prostate Cancer Cells
Lin Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2015)
Downregulation of microRNA-21 expression restrains non-small cell lung cancer cell proliferation and migration through upregulation of programmed cell death 4
Y. Yang et al.
CANCER GENE THERAPY (2015)
High mobility group a proteins as tumor markers
Pierlorenzo Pallante et al.
FRONTIERS IN MEDICINE (2015)
MG132, a proteasome inhibitor, enhances LDL uptake in HepG2 cells in vitro by regulating LDLR and PCSK9 expression
Hong Yan et al.
ACTA PHARMACOLOGICA SINICA (2014)
KRAS and YAP1 Converge to Regulate EMT and Tumor Survival
Diane D. Shao et al.
CELL (2014)
Amplification of MPZL1/PZR promotes tumor cell migration through Src-mediated phosphorylation of cortactin in hepatocellular carcinoma
Deshui Jia et al.
CELL RESEARCH (2014)
The Hippo signaling pathway in stem cell biology and cancer
Jung-Soon Mo et al.
EMBO REPORTS (2014)
Proteasome inhibitor MG132 induces NAG-1/GDF15 expression through the p38 MAPK pathway in glioblastoma cells
Sachie Shimizu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
HMGA2 Is a Driver of Tumor Metastasis
Asahiro Morishita et al.
CANCER RESEARCH (2013)
Roles of Epithelial-Mesenchymal Transition in Cancer Drug Resistance
Yulong Shang et al.
CURRENT CANCER DRUG TARGETS (2013)
SurvExpress: An Online Biomarker Validation Tool and Database for Cancer Gene Expression Data Using Survival Analysis
Raul Aguirre-Gamboa et al.
PLOS ONE (2013)
HMGA2 Overexpression-Induced Ovarian Surface Epithelial Transformation Is Mediated Through Regulation of EMT Genes
Jingjing Wu et al.
CANCER RESEARCH (2011)
Overexpression of HMGA2 Promotes Metastasis and Impacts Survival of Colorectal Cancers
Xiaochen Wang et al.
CLINICAL CANCER RESEARCH (2011)
HMGA2 Maintains Oncogenic RAS-Induced Epithelial-Mesenchymal Transition in Human Pancreatic Cancer Cells
Sugiko Watanabe et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
HMGA2 protein expression correlates with lymph node metastasis and increased tumor grade in pancreatic ductal adenocarcinoma
Alexandra C. Hristov et al.
MODERN PATHOLOGY (2009)
The High Mobility Group Protein HMGA2: A Co-Regulator of Chromatin Structure and Pluripotency in Stem Cells?
Kurt Pfannkuche et al.
STEM CELL REVIEWS AND REPORTS (2009)
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Kornelia Polyak et al.
NATURE REVIEWS CANCER (2009)
Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 MicroRNA family
Kazuo Motoyama et al.
CLINICAL CANCER RESEARCH (2008)
HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias
Gennaro Chiappetta et al.
EUROPEAN JOURNAL OF CANCER (2008)
HMGA2 participates in transformation in human lung cancer
Francescopaolo Di Cello et al.
MOLECULAR CANCER RESEARCH (2008)
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2007)
Let-7 expression defines two differentiation stages of cancer
Scott Shell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
HMGA2 overexpression in non-small cell lung cancer
Britta Meyer et al.
MOLECULAR CARCINOGENESIS (2007)
Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation
Christine Mayr et al.
SCIENCE (2007)
Increased expression of high mobility group A proteins in lung cancer
V. K. Sarhadi et al.
JOURNAL OF PATHOLOGY (2006)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Yes-associated protein and p53-binding protein-2 interact through their WW and SH3 domains
X Espanel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
